论文部分内容阅读
Objective Chronic myelomonocytic leukemia (CMML) has been categorized as an uncommon hematological malignancy with overlapping features of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms that have an inherent risk of progressing to acute